Latest updates on cancer treatment
The American Society of Clinical Oncology (ASCO) 2025 annual meeting, held from May 30 to June 3, 2025, featured significant clinical developments across multiple cancer treatment modalities, with particular attention to antibody-drug conjugates (ADCs), CAR-T cell therapies, and immuno-oncology agents.
ASCO 2025 Highlights: Key Clinical Developments and Regulatory Updates Read More »
The past two months have brought exciting progress in cancer care, with new therapies offering hope for better outcomes and fewer side effects. Below, we break down the latest updates in simple terms, focusing on how these advances might help patients and families navigate treatment decisions.
Cancer Treatment Breakthrough Updates – April / May 2025 Read More »
Key advancements across cancer types from AACR 2025 highlight progress in targeted therapies, immunotherapies, and innovative technologies, with several treatments entering late-stage development or regulatory review
Treatment Progress: Key Findings from AACR 2025 Read More »
